Alternating hepatic arterial infusion and systemic chemotherapy for stage IV colorectal cancer with synchronous liver metastasis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Oncology Report

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/OR.16.4.865PMID 16969507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predicting recurrence and metastasis of primary esophageal cancer with or without lymph node metastasis.

  2006cited by this paper
• Recurrence and 5-FU sensitivity of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses.

  2005cited by this paper
• Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.

  2005cited by this paper
• Recurrence and 5-FU sensitivity of stage II/III node-positive gastric cancer with occult neoplastic cells in lymph node sinuses.

  2005cited by this paper
• Recurrence and 5-FU sensitivity of stage II/Dukes' B colorectal cancer with occult neoplastic cells in lymph node sinuses.

  2005cited by this paper
• Occult neoplastic cells and malignant micro-aggregates in lymph node sinuses: review and hypothesis.

  2005cited by this paper
• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  2004cited by this paper
• Criteria for predicting the recurrence and metastasis of stage I and II gastric cancer without lymph node metastasis.

  2004cited by this paper
• Accuracy of criteria for predicting recurrence and metastasis in stage II and III gastric cancer patients with lymph node metastasis.

  2004cited by this paper
• Predicting the recurrence/metastasis of stage I and II breast cancer without lymph node metastasis.

  2004cited by this paper
• Predicting the recurrence/metastasis of stage II and III breast cancer with lymph node metastasis.

  2004cited by this paper
• Predicting recurrence and metastasis of stage II/Dukes' B colorectal cancer without lymph node metastasis.

  2004cited by this paper
• Predicting recurrence and metastasis of Dukes' A primary colorectal cancer with or without proper muscle invasion.

  2004cited by this paper
• Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancer.

  2004cited by this paper
• Predicting recurrence and metastasis of stage III/Dukes' C colorectal cancer with lymph node metastasis.

  2004cited by this paper
• Lymph node size and metastatic infiltration in non-small cell lung cancer.

  2003cited by this paper
• Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.

  2003cited by this paper
• Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer.

  2003cited by this paper
• Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer.

  2003cited by this paper
• Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer

  2002cited by this paper
• Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.

  2001cited by this paper
• Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification.

  2001cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000influential reference
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

  2000influential reference
• Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

  1999cited by this paper
• Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma

  1998cited by this paper
• Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma

  1998cited by this paper
• Preparation of the antibodies against recombinant human thymidylate synthase for the detection of its intratumoral levels and the application to sensitivity-study of 5-fluorouracil.

  1997cited by this paper
• Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries.

  1995cited by this paper
• Patterns of recurrence after curative resection of carcinoma of the colon and rectum.

  1992cited by this paper
• Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.

  1991cited by this paper
• The Modulation of Fluorouracil With Leucovorin in Metastatic Colorectal Carcinoma A Prospective Randomized Phase III Trial

  1990cited by this paper
• The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.

  1989cited by this paper
• The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

  1985cited by this paper
• Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.

  1984cited by this paper
• Malignant Tumors

  1828cited by this paper

• Clinical question : Management metastatic resectable

  2020cites this paper
• Clinical comparison of QOL and adverse events during postoperative adjuvant chemotherapy in outpatients with node-positive colorectal cancer or gastric cancer.

  2009cites this paper
• Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage II colorectal cancer.

  2008cites this paper
• Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer.

  2008cites this paper
• Local recurrence and occult neoplastic cells in the extranodal fat of dissected lymph nodes in patients with curatively resected primary colorectal cancer.

  2007cites this paper
• Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

  2007cites this paper
• Sensitivity to CPT-11 and platinum derivatives of stage II/III node-positive gastric cancer with occult neoplastic cells in lymph node sinuses

  2007cites this paper
• Sensitivity to CPT-11 and platinum derivatives of stage II/Dukes' B colorectal cancer with occult neoplastic cells in lymph node sinuses.

  2007cites this paper
• Sensitivity to CPT-11 and platinum derivatives of stage I/II node-negative breast, lung, and gastric cancer with occult neoplastic cells in lymph node sinuses.

  2007cites this paper
• Pelvic recurrence after Miles' operation for anastomotic recurrence in a patient with stage I rectal cancer invading the proper muscle layer: Case report.

  2007cites this paper
• Sensitivity to CPT-11 and platinum derivatives of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses.

  2007cites this paper